Pharmacy Board Shuts Down North Carolina Pharmacy

April 2, 2015
Ryan Marotta, Assistant Editor

A number of sterility concerns have prompted the FDA and the North Carolina Board of Pharmacy to warn health care providers, veterinarians, and patients not to use products made and distributed by the Prescription Center pharmacy in Fayetteville.

A number of sterility concerns have prompted the FDA and the North Carolina Board of Pharmacy (NC BOP) to warn health care providers, veterinarians, and patients not to use products made and distributed by the Prescription Center pharmacy in Fayetteville, NC.

The Prescription Center, located on 915 Hay St, was shut down by the NC BOP after a recent inspection raised concerns about the pharmacy’s ability to maintain the sterility of its products. The Board also ordered a recall of all sterile and non-sterile products that were distributed by the Prescription Center between September 10, 2014, and March 10, 2015.

Health care professionals should check their medical supplies and quarantine any drug products from the Prescription Center. To date, the FDA is not aware of any adverse events associated with products distributed by the pharmacy.

In addition to contacting their health care professionals, patients who have experienced adverse reactions to products obtained from the Prescription Center should report them to the FDA’s MedWatch Adverse Event Reporting program. Patients can submit the form online at www.fda.gov/medwatch/report.htm, download it at www.fda.gov/MedWatch/getforms.htm, or call 1-800-332-1088 to request it. Completed paper forms can be returned to the address on the pre-addressed form or faxed to 1-800-FDA-0178.